A-A-54459
31 July 1991
COMMERCIAL ITEM DESCRIPTION
PANCRELIPASE CAPSULES, USP
The General Services Administration has authorized the use of this Commercial Item Description as a replacement for Military Specification MIL-P-37519 which is cancelled.
Salient characteristics:
Shall be Pancrelipase Capsules, USP.
Shall be in accordance with the requirements of the USP.
All ingredients shall be of a pharmaceutical grade.
Workmanship. The capsules shall be free from defects which detract from their appearance or impair their serviceability.
Unit. Bottle (BT).
For Size 1 – One bottle containing 100 capsules, as specified, constitutes one unit.
For Size 2 – One bottle containing 500 capsules, as specified, constitutes one unit.
Contractor certification. The contractor shall certify that the product offered meets the salient characteristics of this description and conforms to the producers’ own drawings, specifications, standards, and quality assurance practices. The Government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business